[{"Assets_0_Q2_USD":3307430000.0,"CIK":"879169","CommonStockSharesConverted_0_Q2_shares":218903097.0,"CommonStockSharesOutstanding_0_Q2_shares":218903097.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":-0.07,"EarningsPerShareBasic_3_Q2_USD":-2.05,"EarningsPerShareDiluted_1_Q2_USD":-0.07,"EarningsPerShareDiluted_3_Q2_USD":-2.05,"Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","Market Cap":"17588712770.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q2_USD":-231920000.0,"NetIncomeLossConverted_1_Q2_USD":-15203000.0,"NetIncomeLossConverted_3_Q2_USD":-445547000.0,"OfficialName":"Incyte Corp. Common Stock","RevenuesConverted_1_Q2_USD":620643000.0,"RevenuesConverted_3_Q2_USD":1877193000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q2_USD":2390833000.0,"Ticker":"INCY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":218784000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q2_shares":217684000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":218784000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q2_shares":217684000.0,"filed":"20201105","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2020.0","name":"INCYTE CORP","period":"20200930","qtrs":"1","uom":"USD"}]